JP2006519824A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519824A5 JP2006519824A5 JP2006505924A JP2006505924A JP2006519824A5 JP 2006519824 A5 JP2006519824 A5 JP 2006519824A5 JP 2006505924 A JP2006505924 A JP 2006505924A JP 2006505924 A JP2006505924 A JP 2006505924A JP 2006519824 A5 JP2006519824 A5 JP 2006519824A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- administered
- disease
- treatment
- side effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 *C([C@](CO)O[C@]1[n]2c(nc(*)nc3N)c3nc2)=C1O Chemical compound *C([C@](CO)O[C@]1[n]2c(nc(*)nc3N)c3nc2)=C1O 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0305150.5A GB0305150D0 (en) | 2003-03-07 | 2003-03-07 | Use of therapeutic compounds |
| PCT/GB2004/000952 WO2004078184A1 (en) | 2003-03-07 | 2004-03-05 | Use of adenosine receptor agonists in therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012001451A Division JP2012111764A (ja) | 2003-03-07 | 2012-01-06 | アデノシン受容体アゴニストの治療上の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519824A JP2006519824A (ja) | 2006-08-31 |
| JP2006519824A5 true JP2006519824A5 (https=) | 2007-05-10 |
Family
ID=9954248
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006505924A Ceased JP2006519824A (ja) | 2003-03-07 | 2004-03-05 | アデノシン受容体アゴニストの治療上の使用 |
| JP2012001451A Pending JP2012111764A (ja) | 2003-03-07 | 2012-01-06 | アデノシン受容体アゴニストの治療上の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012001451A Pending JP2012111764A (ja) | 2003-03-07 | 2012-01-06 | アデノシン受容体アゴニストの治療上の使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7790698B2 (https=) |
| EP (1) | EP1603576A1 (https=) |
| JP (2) | JP2006519824A (https=) |
| KR (1) | KR20050115895A (https=) |
| CN (2) | CN1809365A (https=) |
| AU (1) | AU2004216891B2 (https=) |
| CA (1) | CA2514848A1 (https=) |
| GB (1) | GB0305150D0 (https=) |
| NO (1) | NO20054475L (https=) |
| NZ (1) | NZ541587A (https=) |
| WO (1) | WO2004078184A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0228723D0 (en) * | 2002-12-09 | 2003-01-15 | Cambridge Biotechnology Ltd | Treatment of pain |
| GB0305153D0 (en) * | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Identification of therapeutic compounds |
| GB0305150D0 (en) * | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Use of therapeutic compounds |
| CA2557285A1 (en) * | 2004-03-05 | 2005-09-15 | Cambridge Biotechnology Limited | Adenosine receptor agonists |
| AR049384A1 (es) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | Derivados de purina |
| JP2008519029A (ja) * | 2004-11-08 | 2008-06-05 | キャン−ファイト・バイオファーマ・リミテッド | 加速骨吸収の治療的処置 |
| JP2008527002A (ja) * | 2005-01-13 | 2008-07-24 | サートリス ファーマシューティカルズ， インコーポレイテッド | 神経変性障害および血液凝固障害を予防および処置するための新規組成物 |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| JP5339916B2 (ja) * | 2005-11-30 | 2013-11-13 | キャン−ファイト・バイオファーマ・リミテッド | 骨関節炎の治療におけるａ３アデノシン受容体アゴニストの使用 |
| AU2007263728A1 (en) | 2006-06-27 | 2008-01-03 | Biovitrum Ab (Publ) | Adenosine derivatives for the treatment of pain |
| WO2008000743A2 (en) | 2006-06-27 | 2008-01-03 | Biovitrum Ab (Publ) | Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists |
| BRPI0713902A2 (pt) | 2006-06-27 | 2012-11-27 | Biovitrum Ab | compostos terapêuticos |
| US20120165285A1 (en) * | 2009-07-09 | 2012-06-28 | Peter Richardson | Combined preparation for use as a medicament |
| CN101947230B (zh) * | 2010-08-25 | 2012-10-10 | 苗志敏 | 5’-amp用于治疗痛风性关节炎的用途 |
| CN103342727A (zh) * | 2013-07-01 | 2013-10-09 | 淮海工学院 | 一种2-甲氧基腺苷的合成方法 |
| CN108329372B (zh) * | 2017-01-20 | 2022-07-26 | 浙江省亚热带作物研究所 | N6-(2-羟乙基)腺苷及其衍生物在制备治疗痛风药物中的应用 |
| JP7025129B2 (ja) * | 2017-05-17 | 2022-02-24 | 小林製薬株式会社 | 筋痙攣治療剤 |
| US20220218712A1 (en) * | 2019-02-25 | 2022-07-14 | Saint Louis University | Treatment of alzheimer's disease |
| JPWO2022050230A1 (https=) * | 2020-09-03 | 2022-03-10 | ||
| CN113116900B (zh) * | 2021-04-14 | 2022-07-08 | 兰州大学 | 一类核苷类似物在制备预防和/或治疗脑血管疾病药物中的应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4861498A (https=) | 1971-12-01 | 1973-08-28 | ||
| BE792155A (fr) | 1971-12-01 | 1973-05-30 | Takeda Chemical Industries Ltd | Nouveaux derives de l'adenosine et leur procede de production |
| DE2359536C2 (de) | 1972-12-08 | 1984-08-02 | Takeda Chemical Industries, Ltd., Osaka | 2,6-Diaminonebularinderivate |
| JPS5461194A (en) | 1977-10-21 | 1979-05-17 | Takeda Chem Ind Ltd | Preparation of n22substituted 2*66diaminonebularin |
| JPS5461195A (en) | 1977-10-21 | 1979-05-17 | Takeda Chem Ind Ltd | N2-substituted phenyl-2,6-diaminonebularin |
| US4705758A (en) | 1984-06-19 | 1987-11-10 | Warner-Lambert Company | Adenosine receptor assay and kit |
| US5231086A (en) * | 1985-09-24 | 1993-07-27 | Item Development Aktiebolag | Continuous administration adenosine to increase myocardial blood flow |
| US5104859A (en) * | 1985-09-24 | 1992-04-14 | Solimedco Aktiebolag | Continuous administration of adenosine to reduce pulmonary vascular resistance |
| US5679650A (en) * | 1993-11-24 | 1997-10-21 | Fukunaga; Atsuo F. | Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine |
| US6004945A (en) * | 1990-05-10 | 1999-12-21 | Fukunaga; Atsuo F. | Use of adenosine compounds to relieve pain |
| US6180616B1 (en) * | 1990-05-10 | 2001-01-30 | Atsuo F. Fukunaga | Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function |
| US5677290A (en) * | 1990-05-10 | 1997-10-14 | Fukunaga; Atsuo F. | Therapeutic use of adenosine compounds as surgical anesthetics |
| US5683989A (en) * | 1993-12-17 | 1997-11-04 | Novo Nordisk A/S | Treatment of ischemias by administration of 2,N6 -substituted adenosines |
| US5877180A (en) * | 1994-07-11 | 1999-03-02 | University Of Virginia Patent Foundation | Method for treating inflammatory diseases with A2a adenosine receptor agonists |
| IT1275420B (it) | 1995-06-02 | 1997-08-05 | Schering Plough S P A | Metodo per misurare l'affinita' di legame al recettore a2a dell'adenosina di componenti di interesse farmacologico mediante l'uso del ligando triziato (3h)-sch 58261 |
| JP2002500188A (ja) * | 1998-01-08 | 2002-01-08 | ザ・ユニバーシティ・オブ・バージニア・パテント・ファウンデーション | Ａ２ａアデノシンレセプター作動因子 |
| US20030008841A1 (en) * | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
| GB0305150D0 (en) * | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Use of therapeutic compounds |
| GB0305153D0 (en) | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Identification of therapeutic compounds |
| GB0305149D0 (en) * | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Compounds for the treatment of pain |
-
2003
- 2003-03-07 GB GBGB0305150.5A patent/GB0305150D0/en not_active Ceased
-
2004
- 2004-03-05 JP JP2006505924A patent/JP2006519824A/ja not_active Ceased
- 2004-03-05 CA CA002514848A patent/CA2514848A1/en not_active Abandoned
- 2004-03-05 NZ NZ541587A patent/NZ541587A/en unknown
- 2004-03-05 US US10/547,454 patent/US7790698B2/en not_active Expired - Fee Related
- 2004-03-05 WO PCT/GB2004/000952 patent/WO2004078184A1/en not_active Ceased
- 2004-03-05 CN CNA2004800057235A patent/CN1809365A/zh active Pending
- 2004-03-05 AU AU2004216891A patent/AU2004216891B2/en not_active Ceased
- 2004-03-05 KR KR1020057016713A patent/KR20050115895A/ko not_active Ceased
- 2004-03-05 EP EP04717693A patent/EP1603576A1/en not_active Withdrawn
- 2004-03-05 CN CN201010524262XA patent/CN102058614A/zh active Pending
-
2005
- 2005-09-27 NO NO20054475A patent/NO20054475L/no not_active Application Discontinuation
-
2010
- 2010-09-02 US US12/875,035 patent/US20110166093A1/en not_active Abandoned
-
2012
- 2012-01-06 JP JP2012001451A patent/JP2012111764A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006519824A5 (https=) | ||
| TW199861B (https=) | ||
| JP2020537657A5 (https=) | ||
| JP2019519598A5 (https=) | ||
| JP2016520134A (ja) | ヤヌスキナーゼ（ｊａｋ）阻害剤の硫酸水素塩およびその製造方法 | |
| JP2007526291A5 (https=) | ||
| US10913766B2 (en) | Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and application thereof | |
| JP2007508336A5 (https=) | ||
| EP1460077A1 (en) | Novel pyrazolopyrimidones and their use as PDE inhibitors | |
| JP2014510746A5 (https=) | ||
| CN1387530A (zh) | 用作磷酸二酯酶vii抑制剂的咪唑并吡啶衍生物 | |
| JP2006519823A5 (https=) | ||
| US11883423B2 (en) | Nucleobase analogue derivatives and their applications | |
| JP2010518154A5 (https=) | ||
| JP2023538645A (ja) | ボロン酸化合物 | |
| JP2009541436A5 (https=) | ||
| EP2305680A2 (en) | Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol | |
| WO2018217139A4 (ru) | Новые ингибиторы глутаминилциклаз и их применение для лечения различных заболеваний | |
| WO2009089702A1 (en) | Stable 6-methoxy-2',3'-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same | |
| JP7522414B2 (ja) | Ｊａｋキナーゼ阻害剤、その調製および適用 | |
| JP2011504890A5 (https=) | ||
| EP0999840B1 (en) | Use of a draflazine analogue for treating pain | |
| US12409179B2 (en) | Pharmaceutical combination of pimozide and methotrexate and use thereof | |
| CA2768290C (en) | R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for thepreparation thereof and pharmaceutical composition comprising the same for antimicrobial | |
| CN113082023A (zh) | P2x3抑制剂和p2x4抑制剂的药物组合及其应用 |